Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Resilience Capital Partners is a U.S.-based private equity firm focused on investing in lower middle market companies rather than developing drugs or healthcare products. Founded in 2001 and headquartered in Cleveland, Ohio, the firm describes its strategy as long-term, value-oriented investing with operational support for portfolio companies. Its investment focus spans niche manufacturing, value-added distribution, and business services, and its portfolio has included industrial, aerospace, imaging, labeling, and related operating companies. Based on the available evidence, Resilience Capital Partners is not itself a life sciences, biotech, pharma, or healthcare operating company, although it may invest in companies across multiple sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Resilience Capital Partners.